{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05318027",
            "orgStudyIdInfo": {
                "id": "UPCC 18921"
            },
            "organization": {
                "fullName": "Abramson Cancer Center at Penn Medicine",
                "class": "OTHER"
            },
            "briefTitle": "ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy",
            "officialTitle": "Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "chatbot-and-activity-monitoring-in-patients-undergoing-chemoradiotherapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-06",
            "studyFirstSubmitQcDate": "2022-04-07",
            "studyFirstPostDateStruct": {
                "date": "2022-04-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Abramson Cancer Center at Penn Medicine",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits\n\nCorrelate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks"
        },
        "conditionsModule": {
            "conditions": [
                "Lung Cancer",
                "Gastrointestinal Cancer",
                "Head and Neck Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 70,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Activity Monitoring and ChatBot",
                    "type": "EXPERIMENTAL",
                    "description": "Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring and utilize a ChatBot",
                    "interventionNames": [
                        "Device: ChatBot"
                    ]
                },
                {
                    "label": "Activity Monitoring without ChatBot",
                    "type": "NO_INTERVENTION",
                    "description": "Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring alone"
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "ChatBot",
                    "description": "The automated chatbot will check in with the patient on two pre-specified days between scheduled outpatient visits. The chatbot will follow pre-specified symptom algorithms and classify symptoms as requiring high, intermediate and low risk follow ups. High risk symptoms will trigger a same day nursing/physician visit or telemedicine call/video. Intermediate risk symptoms will trigger a nursing triage visit or telemedicine call/video on the next day or treatment day. Low risk symptoms will notify the treating physician to address the symptoms at the next scheduled on treatment visit (OTV). If adjustments are needed in the chat bot triage algorithms, they will be updated in real time to decrease risk for adverse patient events.",
                    "armGroupLabels": [
                        "Activity Monitoring and ChatBot"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of triage visits",
                    "description": "Difference between Poisson event rates of triage visits between intervention and control arms",
                    "timeFrame": "13 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Count of unplanned inpatient hospitalization",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Count of treatment breaks",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Count of emergency department visits",
                    "timeFrame": "13 weeks"
                },
                {
                    "measure": "Quality of Life scores",
                    "timeFrame": "13 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults (age \\>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment.\n* Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly\n* Ability read and respond in English\n* Ability to provide informed consent to participate in the study\n\nExclusion Criteria:\n\n* Patients who are bed bound at baseline (ECOG 4)\n* Patients who rely on a wheelchair for ambulation",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Michell Kim",
                    "role": "CONTACT",
                    "phone": "215-760-2487",
                    "email": "Michell.Kim@pennmedicine.upenn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Arun Goel, MD",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Kristine Kim, MD",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Nishant Shah, MD",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Abramson Cancer Center of the University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Arun Goel, MD",
                            "role": "CONTACT",
                            "phone": "215-662-6059",
                            "email": "Arun.Goel@pennmedicine.upenn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "27413701",
                    "type": "BACKGROUND",
                    "citation": "Uyterlinde W. Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer. Transl Lung Cancer Res. 2016 Jun;5(3):239-43. doi: 10.21037/tlcr.2016.05.03."
                },
                {
                    "pmid": "26514533",
                    "type": "BACKGROUND",
                    "citation": "Ghosh S, Rao PB, Kumar PR, Manam S. Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment. Asian Pac J Cancer Prev. 2015;16(16):7331-5. doi: 10.7314/apjcp.2015.16.16.7331."
                },
                {
                    "pmid": "24485047",
                    "type": "BACKGROUND",
                    "citation": "Haj Mohammad N, Hulshof MC, Bergman JJ, Geijsen D, Wilmink JW, van Berge Henegouwen MI, van Laarhoven HW. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma. BMC Cancer. 2014 Jan 31;14:56. doi: 10.1186/1471-2407-14-56."
                },
                {
                    "pmid": "25413398",
                    "type": "BACKGROUND",
                    "citation": "Waddle MR, Chen RC, Arastu NH, Green RL, Jackson M, Qaqish BF, Camporeale J, Collichio FA, Marks LB. Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factors. Pract Radiat Oncol. 2015 May-Jun;5(3):e245-e253. doi: 10.1016/j.prro.2014.08.004. Epub 2014 Sep 17."
                },
                {
                    "pmid": "20351327",
                    "type": "BACKGROUND",
                    "citation": "Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29."
                },
                {
                    "pmid": "19528407",
                    "type": "BACKGROUND",
                    "citation": "Lang K, Sussman M, Friedman M, Su J, Kan HJ, Mauro D, Tafesse E, Menzin J. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2009 Jun;135(6):582-8. doi: 10.1001/archoto.2009.46."
                },
                {
                    "pmid": "28387544",
                    "type": "BACKGROUND",
                    "citation": "Beg MS, Gupta A, Stewart T, Rethorst CD. Promise of Wearable Physical Activity Monitors in Oncology Practice. J Oncol Pract. 2017 Feb;13(2):82-89. doi: 10.1200/JOP.2016.016857."
                },
                {
                    "pmid": "16818906",
                    "type": "BACKGROUND",
                    "citation": "McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006 Jul 4;175(1):34-41. doi: 10.1503/cmaj.051073."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "asFound": "Gastrointestinal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}